stella
beta
A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura® — Stella
Home
/
Asthma
/
A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®
View on ClinicalTrials.gov
Recruiting
Back to Asthma trials
A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®
Trial locations
(18 sites)
South Korea
Novartis Investigative Site, Daegu, Dalseo gu
Novartis Investigative Site, Kangwon Do, Gangneung si
Novartis Investigative Site, Wŏnju, Gangwon-do
Novartis Investigative Site, Goyang-si, Gyeonggi-do
Novartis Investigative Site, Guri-si, Gyeonggi-do
Novartis Investigative Site, Jeonju, Jeollabuk-do
Novartis Investigative Site, Iksan Si, Jeonlabuk Do
Novartis Investigative Site, Daejeon, Korea
Novartis Investigative Site, Busan
Novartis Investigative Site, Gyeongsangnam Do
Novartis Investigative Site, Jeju City
Novartis Investigative Site, Jinju
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Taegu
Novartis Investigative Site, Ulsan